$NICE

Wed: Nice bucks market

Tel Aviv Stock Exchange indices fell, with Tel Aviv 35 down 0.26% and BlueTech Global down 0.12%. Nice gained 1.68% on acquisition rumors, while Camtek dropped 2.73%. Banking and retail sectors saw declines. Turnover was NIS 3.84B in equities and NIS 6.63B in bonds.

Original reporting
Published Sep 23, 2026, 6:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 6:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Wed: Nice bucks market — source image
Decision brief

The 30-second read

$NICEBullishMed
01

Why it matters

The acquisition rumor provides a catalyst for Nice, while other Israeli stocks remain pressured.

02

Market read

Nice's move stands out in a broadly down market, highlighting deal‑driven volatility.

03

What to watch

Regulatory approval risk and integration challenges.

Relevance 7/10Novelty 8/10Timing: today

Background

Tel Aviv market declined overall, but Nice gained on acquisition rumor.

Company-level read

Ticker impact

$NICEBullishHigh confidence
Context

Nice rose 1.68% on reports of a possible $2 billion acquisition of Actimize.

Expected impact

Expect modest upside of 2‑4% if acquisition rumors persist.

Evidence & confidence

Rumor of a large deal and immediate price reaction indicate market sensitivity.

Market effects

Potential consolidation in cybersecurity could affect peers like Palo Alto Networks and Fortinet.

Positive sentiment for Israeli tech stocks on TASE.

May influence broader cybersecurity market sentiment.

Counterpoint

Deal may fall through; price could correct.

Key entities

  • Nice

    NASDAQ‑listed cybersecurity firm.

  • Actimize

    Target of the rumored acquisition.

Related articles

$NICEHighAI 9/10

Brookfield in talks to buy Nice’s Actimize for $2b - report

Brookfield is in talks to acquire Actimize from NICE for $2 billion, though the deal is not finalized. NICE, with a $6.9 billion market cap, has seen low single-digit stock gains this year. Brookfield manages over $1 trillion in assets and has a $73.5 billion market cap. NICE reported Q2 2026 revenue of $782 million, with $83.2 million in net profit.

$NICEMed

NICE Soars As AI Pivot And Upgrade Spark Rally

NICE Ltd. (NICE) shares rose after an analyst upgraded the stock to Buy and the company announced plans to sell its Actimize unit for $2B to focus on AI and cloud platforms. The rally follows a strong Q2 earnings beat and new customer wins. The company has strong margins and cash generation but faces challenges in revenue conversion and profit pressure.

$NICEHighAI 9/10

NICE (NICE) Q2 2026 Earnings Call Transcript

NICE Ltd. reported Q2 2026 revenue of $782 million, up 8% year over year, and cloud revenue of $609 million, up 12.6%. Non-GAAP EPS was $2.70. Management cited CX AI and self-service ARR of $362 million (+52%), operating margin of 25.3%, and free cash flow of $93 million. Full-year 2026 revenue guidance is $3.170B to $3.190B.

$NICEHigh

NICE Ltd. (NICE): Financial results for Q2 2026

NICE Ltd. (NICE) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 NiCE Exceeds Revenue Guidance Range, Reporting 8% Year-Over-Year Revenue Growth in Second Quarter 2026 • Total revenue growth driven by 12.6% year over year cloud revenue growth • International revenue increased 22% year over year (21% in constant currency) • Company

$TEVAMed

Wed: Teva jumps but TASE continues to lose ground

Globes reports the Tel Aviv Stock Exchange fell on July 29, with the Tel Aviv 35 down 0.99% and Tel Aviv 125 down 0.96%. Teva Pharmaceutical (NYSE: TEVA; TASE: TEVA) rose 10.17% after Q2 results and raised revenue guidance. Other movers included Enlight Renewable Energy, Elbit Systems, and banks such as Bank Leumi and Hapoalim.